no weight loss first month of semaglutide JOURNEY RECAP // How I lost 30 lbs in 3 months, milestones, challenges + sustainability Semaglutide | Weight Loss around

GLP-1 agonists were initially approved for treating type 2 diabetes, with subsequent approvals for chronic weight management and reduction of the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 diabetes

At best, they are marketing additions, not therapy components

Your physician will likely recommend monitoring your TSH levels more closely after starting semaglutide

The science behind our approach is robust, drawing from research in amino acid supplementation, cellular regeneration, and advanced collagen stimulation techniques

Despite these favorable mechanisms, concerns remain regarding the impact of GLP-1 RAs on lean body mass (LBM) and the potential risk of sarcopenia

Garelja ML, Hay D, Poyner DR, Walker CS